Main description:

The Clinical Handbook of Psychotropic Drugs has become a standard reference and practical tool for psychiatrists, psychiatric nurses, pharmacists, psychologists, physicians, and all mental health professionals.
The new and fully updated 19th edition retains all the practical features for which the Clinical Handbook is renowned: - Independent, unbiased - Packed with unique comparison charts (dosages, side effects, pharmacokinetics, interactions - ) that allow you to see at a glance which medication is the most suitable for each patient - Instantly recognizable icons and full color throughout, allowing you to find at a glance all the information you seek - The latest information on newly released drugs, adverse effects, approved indications (see below for details) - Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug - Patient Handouts, Herbal and NaturalA" Products, Unapproved Treatments, ECT, BLT, rTMS New in this edition: - Pharmacotherapy for nicotine/tobacco use - Extensive revisions and additions to the antipsychotics, including dosing, adverse effects, interactions, precautions - New dosage/pharmacokinetics comparison chart for extrapyramidal agents - Extensive revisions to benzodiazepines and hypnotics/sedatives comparison chart - Updates on unapproved treatments (e.g.
, pregabalin and vigabatrin for alcohol and cocaine dependence) and herbal and naturalA" products (e.g., for treatment of depression) - Hundreds of new references - Printable (PDF) patient handouts - Drugs with recent/changed approval include: iloperidone (Fanapt), asenapine sublingual (Saphris), guanfacine (Tenex, Intuniv), degarelix (Firmagon), finasteride (Proscar) - Preparations added include: Symbyax, Prozac Weekly, Luvox CR, Aplenzin, Oleptro, Silenor, Zonolon, Invega Sustenna, Zyprexa Relprevv, Mellaril, Compoz, Epitol, Teril, Compoz, Nytol, Simply Sleep, Sominex, Unisom, clonidine SR (Kapvay)

Contents:

Table of Contents Antidepressants Selective Serotonin Reuptake Inhibitors (SSRI) * Norepinephrine Dopamine Reuptake Inhibitor (NDRI) * Serotonin Norepinephrine Reuptake Inhibitor (SNRI) * Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) * Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) * Non-Selective Cyclic Antidepressants * Monoamine Oxidase Inhibitors * Reversible Inhibitor of MAO-A (RIMA) * Irreversible Monoamine Oxidase Inhibitors * Monoamine Oxidase B Inhibitor * Effects of Antidepressants on Neurotransmitters/ Receptors * Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors * Frequency of Adverse Reactions to Cyclic Antidepressants at Therapeutic Doses * Frequency (%) of Adverse Reactions to MAOI Antidepressants at Therapeutic Doses * Antidepressant Doses and Pharmacokinetics * Switching Antidepressants * Antidepressant Augmentation Strategies Electroconvulsive Therapy (ECT) Bright-Light Therapy (BLT) Repetitive Transcranial Magnetic Stimulation (rTMS) Antipsychotics Second-GenerationA" Antipsychotics/SGAs * Third-GenerationA" Antipsychotic/TGA * First GenerationA" Antipsychotics/FGAs * Effects of Antipsychotics on Neurotransmitters/Receptors * Pharmacological Effects of Antipsychotics on Neurotransmitters/ Receptors * Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses * Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) * Comparison of Long-acting IM Antipsychotics * Extrapyramidal Adverse Effects of Antipsychotics * Switching Antipsychotics * Antipsychotic Augmentation Strategies Agents for Treating Extrapyramidal Side Effects Effects on Extrapyramidal Symptoms * Comparison of Agents for Treating Extrapyramidal Side Effects * Doses and Pharmacokinetics of Agents for Treating Extrapyramidal Side Effects Anxiolytic (Antianxiety) Agents Benzodiazepines * Comparison of the Benzodiazepines * Buspirone Hypnotics/Sedatives L-Tryptophan * Comparison of Hypnotics/Sedatives Mood Stabilizers Lithium * Anticonvulsants * Comparison of Anticonvulsants * Comparison of Adverse Reactions to Mood Stabilizers at Therapeutic Doses Drugs for ADHD Psychostimulants * Atomoxetine * Comparison of Drugs for ADHD * Alpha-2 Agonists * Augmentation Strategies in ADHD Drugs for Treatment of Dementia Cholinesterase Inhibitors * Memantine * Comparison of Drugs for Treatment of Dementia Sex-Drive Depressants Comparison of Sex-Drive Depressants Drugs of Abuse Alcohol * Stimulants * Hallucinogens * Opiates/Narcotics * Inhalants/Aerosols * Gamma-hydroxy Butyrate (GHB)/Sodium Oxybate * Flunitrazepam (Rohypnol) * Nicotine/Tobacco Treatment of Substance Use Disorders Disulfiram * Acamprosate * Naltrexone * Methadone * Buprenorphine * Pharmacotherapy for Nicotine/Tobacco Use Dependence Unapproved Treatments of Psychiatric Disorders Adrenergic Agents * Dopaminergic Agents * GABA-Agents/Anticonvulsants * Serotonin Antagonists * Hormones * Miscellaneous Herbal and NaturalA" Products Glossary Patient Information Sheets Index of Drugs